Affiliation:
1. Centre for Chronic & Complex Care Research, Blacktown Hospital Western Sydney Local Health District Blacktown New South Wales Australia
2. School of Nursing University of Wollongong Wollongong New South Wales Australia
3. Sutherland Hospital South East Sydney Local Health District Caringbah New South Wales Australia
4. Lived Experience Consumer Sydney New South Wales Australia
5. Hunter Medical Research Institute Newcastle New South Wales Australia
6. School of Nursing & Midwifery, Centre for Quality & Patient Safety in the Institute for Health Transformation Deakin University Burwood Victoria Australia
7. Western Health Partnership St Albans Victoria Australia
Abstract
AbstractAimTo evaluate the effect of a novel, co‐designed, digital AF educational program, ‘INFORM‐AF’, to reduce re‐hospitalisation of people with AF.The secondary aims are to examine the effect of the intervention on: (a) reducing cardiovascular‐related hospitalisation, (b) increasing medication adherence, AF‐related knowledge, and Atrial fibrillation (AF)‐related quality of life and (c) determining the cost‐effectiveness of the intervention.BackgroundAF is an increasingly prevalent cardiac arrythmia that involves complex clinical management. Comprehensive education is essential for successful self‐management of AF and is associated with positive health‐related outcomes. There has been an increase in technology‐based education for AF. However, its effects on hospitalisation, medication adherence and patient‐reported outcomes are unclear.DesignA prospective, randomised (1:1), open‐label, blinded‐endpoint, multicentre clinical trial.MethodsEligible participants are aged 18 years or above, diagnosed with AF, and own a smartphone. The study will be conducted at two metropolitan hospitals. In the intervention group, participants will receive the AF educational program delivered via Qstream®. In the control group, participants will receive the Stroke Foundation ‘Living with AF’ booklet. The primary outcome is re‐hospitalisation within 12 months from an indexed presentation or hospital admission.ConclusionThis clinical trial is part of a developing program of work that will examine mHealth educational‐behavioural interventions on cardiovascular outcomes. Findings from this pilot study will inform the development of a digital educational framework for patients living with AF.Implications for the Profession and/or Patient CareThere remain many gaps in providing high‐quality patient education for patients with AF. This trial will test a new theory‐driven, smartphone‐based education program on important clinical outcomes, including rehospitalisation.Impact
This study evaluates a novel, co‐designed, digital AF educational program, ‘INFORM‐AF’, to reduce the re‐hospitalisation of people with AF.
Study results are expected to be reported in 2025.
Findings are expected to inform practice recommendations for AF patient education that may be included in future clinical practice guideline recommendations.
Reporting MethodSPIRIT Checklist.Patient or Publication ContributionJL is a consumer co‐researcher on the project and provided critical input into intervention design, and feedback and input across the study duration.
Reference21 articles.
1. Australian Clinical Trials Alliance. (2018).Consumer involvement consultation report.www.clinicaltrialsalliance.org.au/resource/acta‐consumer‐involvement‐consultationreport‐2/
2. Australian Clinical Trials Alliance. (2019).Toolkit for researchers and research organisations. Retrieved 26/07/2023 fromwww.involvementtoolkit.clinicaltrialsalliance.org.au/toolkit
3. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population;Ball J.;Medical Journal of Australia,2015
4. Antithrombotic therapy in the prevention of stroke;Bir S.;Biomedicine,2021
5. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation;Charlson M. E.;Journal of Chronic Diseases,1987